Xcout Intel
Pharma Two B competitors & alternatives
The 12 closest competitors and alternatives to Pharma Two B among pharmaceuticals companies — ranked by similarity to what Pharma Two B actually does, not by market-cap band.
Subscribe to see Pharma Two B’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Pharma Two B
Pharma Two B Ltd. is a late-clinical stage biopharmaceutical company headquartered in Kiryat Ono, Israel. The company focuses on developing pharmaceutical treatments and therapeutic products for neurological and related medical conditions. It has pursued corporate growth initiatives, including planned public market transactions via mergers.
Pharma Two B at a glance
Pharma Two B is a pharmaceuticals company headquartered in Israel. Its most recent funding round raised $30M in February 2017.
Pharma Two B funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $30M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Pharma Two B competitors
Ranked by semantic similarity — how close each company is to Pharma Two B by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
Abital Pharma Pipelines is an incubator in Israel dedicated to advancing life science innovation. The company collaborates with the Naiot incubator to develop drugs targeting the central nervous system.
Similar pharmaceuticals company
J2 Bio-Pharma, LLC is a specialty pharmaceutical company that reformulates neurology medications to address unmet medical needs. The company partners with pharmacies, patients, and businesses in the healthcare sector to develop and commercialize therapeutic products.
Similar pharmaceuticals company
Wize Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Hod Hasharon, Israel. The company focuses on the development and commercialization of treatments for ophthalmic and other serious medical conditions.
Similar pharmaceuticals company
Abital Pharma is an Israeli therapeutics company founded in 2012 by Prof. Moussa B. H. Youdim, focusing on the development of original drugs and operating as a life science incubator.
Similar pharmaceuticals company
Mapi Pharma is an Israeli pharmaceutical company that develops complex generic and proprietary drug products, with a focus on long-acting injectable formulations. Its products are intended for patients and healthcare providers, and the company works with pharmaceutical partners to develop and commercialize treatments, including therapies for neurological conditions such as multiple sclerosis.
Pharmaceuticals, Biotechnology & Life Sciences
Established in 2002 and headquartered in Cottesloe, Australia, NeuroScientific Biopharmaceuticals Limited specializes in the development of medical therapies for neurodegenerative conditions. The company conducts extensive preclinical and clinical research utilizing its proprietary technological platforms to advance these treatments. Its primary pharmaceutical compound, EmtinB, is being developed as a potential therapeutic agent for diseases including neurodegenerative dementia, Alzheimer's disease, and various degenerative disorders affecting the optic nerve.
Similar pharmaceuticals company
Kamari Pharma (now Orvida Pharma) is a privately held biopharmaceutical company located at the Weizmann Science Park in Ness Ziona, Israel, focused on developing therapeutic treatments.
Similar pharmaceuticals company
Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases.
Similar pharmaceuticals company
Alterity Therapeutics Limited, an Australian biopharmaceutical firm, focuses on the discovery and development of novel drug treatments for various neurological disorders, such as Alzheimer's, Huntington's, and Parkinson's diseases. Its prominent experimental therapy, ATH434, has completed Phase I clinical trials targeting Parkinson's disease. The company is also advancing PBT2, a compound that has successfully undergone Phase IIa clinical testing for Alzheimer's disease. Established in 1997, the entity was formerly known as Prana Biotechnology Limited before rebranding to Alterity Therapeutics Limited in April 2019, and its main operations are based in Melbourne, Australia.
Similar pharmaceuticals company
MSICS Pharma is an Israeli pharmaceutical startup founded in 2022 and headquartered in Ness Ziona. The company develops technology for growing and producing medical-grade psilocybin for pharmaceutical use and is advancing clinical trials for conditions such as PTSD, depression, and OCD.
Similar pharmaceuticals company
Saniona AB is a clinical-stage biopharmaceutical company that discovers and develops treatments for neurological disorders and rare diseases. The company utilizes its proprietary ion channel drug discovery engine and proprietary molecule library to advance a pipeline of potential new medicines targeting conditions such as epilepsy and hypothalamic obesity.
Pharmaceuticals, Biotechnology & Life Sciences
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Pharma Two B and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Pharma Two Band every competitor above — in one live dashboard.
Subscribe to Xcout Intel →